As the government considers reclassifying cannabis, researchers say easing the rules could lead to big advances.

For neuroscientist Chuanhai Cao, the problem with the U.S. Drug Enforcement Administration’s classification of marijuana as a Schedule I drug can be summed up in two words: dead mice.

Cao, a researcher at the University of South Florida’s Byrd Alzheimer’s Institute, uses transgenic mice to study the effect of the marijuana component tetrahydrocannabinol (THC) on amyloid beta, the protein that forms the plaque found in the brains of Alzheimer’s patients.

Timing is critical in his work — the mice, which are difficult to breed, have to be a specific age at the time of an experiment.

Click here to read the complete article

David Noonan ~ Scientific American ~

Recent News Articles

Monday May 20

State Treasurers Group Endorses Marijuana Banking Legislation - Cannabis News

in Politics

by Bruce Kennedy - Editor in Chief

A group representing state treasurers and finance officials is formally calling on Congress to pass…

741 hits

Monday May 20

At Vt. Cannabis And Hemp Convention, Some Businesses Having #FOMO - Cannabis News

in Finance

by Bruce Kennedy - Editor in Chief

The Vermont Cannabis and Hemp Convention took place at the Champlain Valley Expo this weekend.

779 hits

Monday May 20

Arizona Farmers Can Begin Growing Hemp in June - Cannabis News

in Cannabis News

by Bruce Kennedy - Editor in Chief

Arizona farmers can begin planting hemp in early June. Hemp industry applications are due by…

1665 hits

Monday May 20

Cannabis-brewed Beer Prepares to Enter the New Canadian Market - Cannabis News

in World News

by Bruce Kennedy - Editor in Chief

The world’s first beer brewed from cannabis will be ready when Canada legalizes cannabis beverages…

1254 hits

Tuesday May 21

Poll: Most of Illinois says marijuana should be legal - Cannabis News

in Politics

by Bruce Kennedy - Editor in Chief

A new poll by Global Strategy Group on behalf of Think Big Illinois, says a…

924 hits